EasyManua.ls Logo

Hologic ThinPrep - Page 9

Hologic ThinPrep
172 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
MAN-05359-001 -001 Rev. 001 page 5 of 32
Table 1. Site Characteristics
Site 1 2 3 4
Screening (Low Risk)
Population
88% 82% 90% 94%
Referral (High Risk)
Population
12% 18% 10% 6%
HSIL+ prevalence
1.1% 0.7% 0.4% 0.6%
ThinPrep Pap Tests Per Year
120,000 70,200 280,000 105,000
Number of Cytotechnologists
14 9 32 11
Number of Cytotechnologists
in Study
2 2 2 2
Number of Cytopathologists
6 5 6 14
Number of Cytopathologists
in Study
1 2 1 2
G.1.2 Descriptive Diagnosis Sensitivity and Specificity Estimates
A panel of three independent cytopathologists adjudicated slides from all discordant (one-grade
or higher cytologic difference) descriptive diagnosis cases (639), all concordant positive cases
(355) and a random 5% subset of the 8550 negative concordant cases (428). The
cytopathologists on the adjudication panel were board-certified, all of whom had a subspecialty
certification in cytopathology. Their experience levels in cytopathology ranged from 6 to 12
years. Two of the adjudicators were from university practices and one adjudicator was from a
private medical center. The volumes for the adjudicators’ institutions ranged from 12,000 to
30,000 ThinPrep Pap Tests annually.
A consensus diagnosis was defined as agreement by at least 2 of 3 cytopathologists. All slides
sent to the panel of cytopathologists were not identified by site nor ordered in any fashion.
When a consensus diagnosis could not be obtained by at least 2 of 3 cytopathologists, the full
panel of cytopathologists reviewed each case simultaneously using a multi-headed microscope
to determine a consensus diagnosis.
The adjudicated results were used as a “gold standard” to define the following major “true”
descriptive diagnosis classifications of the Bethesda System: Negative, ASCUS, AGUS, LSIL,
HSIL, Squamous Cell Carcinoma (SQ CA) and Glandular Cell Carcinoma (GL CA). Estimates
of sensitivity and specificity together with 95% confidence intervals were calculated for the
Manual Review and Imager Review arms of the study. The differences in sensitivity and
specificity between the two arms, together with their 95% confidence intervals were also
calculated. Among the random 5% subset of 8,550 cases (428 slides) that were found to be
negative by both arms and adjudicated, there were 425 “true” negative and 3 “true” ASCUS
slides. A multiple imputation technique was used to adjust the numbers of true positives and
true negatives for the 8,550 negative concordant cases based on the 5% of cases that were
adjudicated
2
.
Table 2 summarizes the descriptive diagnosis sensitivity and specificity estimates with 95%
confidence intervals for all sites combined for “true” ASCUS+, LSIL+ and HSIL+.

Table of Contents

Related product manuals